Table 3.
miRNA-222 expression analysis by (a) one way ANOVA followed by (b) post hoc test multiple comparisons for Tukey’s HSD.
| (a) | ||||||
|---|---|---|---|---|---|---|
| Groups | Sum of squares | df | Mean square | F | Significance | |
| Between groups | 40,662.521 | 2 | 20,331.260 | 89.587 | 0.00001* | |
| Within groups | 12,935.862 | 57 | 226.945 | |||
| Total | 53,598.382 | 59 | ||||
| (b) | ||||||
|---|---|---|---|---|---|---|
| Group A | Group B | Mean difference (A-B) | Std. error | Significance | 95% confidence interval | |
| Lower bound | Upper bound | |||||
| Control | MNG | − 7.49700 | 4.76387 | 0.265 | − 18.9609 | 3.9669 |
| Thyroid cancer patients | − 58.5895** | 4.76387 | 0.000 | − 70.0534 | − 47.1256 | |
| MNG | Control | 7.49700 | 4.76387 | 0.265 | − 3.9669 | 18.9609 |
| Thyroid cancer patients | − 51.09250** | 4.76387 | 0.000 | − 62.5564 | − 39.6286 | |
| Thyroid cancer patients | Control | 58.58950** | 4.76387 | 0.000 | 47.1256 | 70.0534 |
| MNG | 51.09250** | 4.76387 | 0.000 | 39.6286 | 62.5564 | |
*Significance at the 0.05 level.
**The mean difference is significant at the 0.05 level.